Lilly del Caribe, Inc. has submitted a request to the Foreign-Trade Zones (FTZ) Board for new production activities at its facility in Carolina, Puerto Rico. This request involves using specific foreign materials, including orforglipron, which may require certain duty payments based on their origin. Public comments on the proposed production activity are invited until March 24, 2025. The proposed activities and materials need to be approved by the Board and are required to be entered into the FTZ in privileged foreign status due to international trade regulations.
Simple Explanation
Lilly del Caribe wants to make medicines in Puerto Rico using some ingredients from other countries, and people are being asked to say what they think about this plan by March 24, 2025. They need special permission to use these ingredients because of trade rules, and this is all being handled by a government board.